Yu‐Hui Peng

1.5k total citations · 1 hit paper
72 papers, 933 citations indexed

About

Yu‐Hui Peng is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu‐Hui Peng has authored 72 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 20 papers in Oncology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu‐Hui Peng's work include Esophageal Cancer Research and Treatment (25 papers), Gastric Cancer Management and Outcomes (15 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Yu‐Hui Peng is often cited by papers focused on Esophageal Cancer Research and Treatment (25 papers), Gastric Cancer Management and Outcomes (15 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Yu‐Hui Peng collaborates with scholars based in China, India and Germany. Yu‐Hui Peng's co-authors include Yi‐Wei Xu, En‐Min Li, Li‐Yan Xu, Chao‐Qun Hong, Ling‐Yu Chu, Jian‐Jun Xie, Haipeng Guo, Tao Qiu, Tianqi Ming and Haibo Xu and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Carbon.

In The Last Decade

Yu‐Hui Peng

68 papers receiving 925 citations

Hit Papers

Curcumin suppresses colorectal cancer by induction of fer... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis
    2024 43 citations Yu‐Hui Peng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Hui Peng China 18 380 234 192 188 187 72 933
Yi‐Wei Xu China 20 480 1.3× 269 1.1× 225 1.2× 352 1.9× 218 1.2× 97 1.2k
Yu Jiang China 19 389 1.0× 219 0.9× 172 0.9× 194 1.0× 170 0.9× 67 1.1k
Yoshiyuki Yamamoto Japan 19 398 1.0× 269 1.1× 108 0.6× 175 0.9× 185 1.0× 108 1.1k
Yin Liu China 18 294 0.8× 262 1.1× 214 1.1× 127 0.7× 118 0.6× 62 839
Carly C. Barron Canada 15 521 1.4× 273 1.2× 289 1.5× 201 1.1× 161 0.9× 33 1.2k
Mengmeng Wang China 20 440 1.2× 177 0.8× 140 0.7× 237 1.3× 190 1.0× 96 1.2k
Hengyuan Li China 21 342 0.9× 272 1.2× 180 0.9× 180 1.0× 341 1.8× 69 1.4k
Nilgün Kapucuoğlu Türkiye 20 253 0.7× 304 1.3× 187 1.0× 223 1.2× 137 0.7× 74 1000
Yunshan Wang China 19 478 1.3× 482 2.1× 166 0.9× 128 0.7× 246 1.3× 55 1.5k

Countries citing papers authored by Yu‐Hui Peng

Since Specialization
Citations

This map shows the geographic impact of Yu‐Hui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Hui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Hui Peng more than expected).

Fields of papers citing papers by Yu‐Hui Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Hui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Hui Peng. The network helps show where Yu‐Hui Peng may publish in the future.

Co-authorship network of co-authors of Yu‐Hui Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Hui Peng. A scholar is included among the top collaborators of Yu‐Hui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Hui Peng. Yu‐Hui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qinyu, Jie Huang, Xiaoming Shi, et al.. (2025). Associations between dietary B vitamin intakes and cognitive function among elderly individuals: An observational study. Nutrition. 134. 112716–112716. 2 indexed citations
2.
3.
Peng, Yu‐Hui, Anqi Ni, Liping Wu, et al.. (2024). Nitrogen-doped Co/carbon nanosheet composites with accordion-like structures and superior magnetic resonance for broadband electromagnetic wave absorption. Carbon. 234. 119965–119965. 16 indexed citations
4.
Zhang, Biao, Chao‐Qun Hong, Yi‐Wei Lin, et al.. (2023). Association between IGFBP1 expression and cancer risk: A systematic review and meta-analysis. Heliyon. 9(6). e16470–e16470. 3 indexed citations
5.
6.
Chu, Ling‐Yu, Wang‐Kai Fang, Chao‐Qun Hong, et al.. (2023). Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma. Biomedical Journal. 47(4). 100662–100662. 2 indexed citations
7.
Zhang, Biao, et al.. (2022). Prognostic value of IGFBP2 in various cancers: a systematic review and meta‐analysis. Cancer Medicine. 11(16). 3035–3047. 21 indexed citations
8.
Chu, Ling‐Yu, Jianyuan Zhou, Yixuan Zhao, et al.. (2021). Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor. Bioscience Reports. 41(6). 2 indexed citations
9.
Hong, Chao‐Qun, et al.. (2021). Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers. Disease Markers. 2021. 1–10. 5 indexed citations
10.
Chu, Ling‐Yu, Yi‐Wei Lin, Yun Luo, et al.. (2021). A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Cancer Management and Research. Volume 13. 7771–7782. 8 indexed citations
11.
Li, Zheng, Haijie Xu, Jiaming Yu, et al.. (2021). The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma. Cancer Control. 28. 3 indexed citations
12.
13.
Fang, Peng, Yu‐Hui Peng, Wan-Hua Lin, et al.. (2021). Wrist Pulse Recording With a Wearable Piezoresistor-Piezoelectret Compound Sensing System and Its Applications in Health Monitoring. IEEE Sensors Journal. 21(18). 20921–20930. 18 indexed citations
14.
Qiu, Bo, et al.. (2020). <p>Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 12131–12139. 3 indexed citations
15.
Chen, Hao, Chao‐Qun Hong, Ling‐Yu Chu, et al.. (2020). Nomogram based on nutritional and inflammatory indicators for survival prediction of small cell carcinoma of the esophagus. Nutrition. 84. 111086–111086. 8 indexed citations
16.
Xu, Yi‐Wei, Hong Guo, Chao‐Qun Hong, et al.. (2019). Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma. Gut and Liver. 14(6). 727–734. 6 indexed citations
17.
Chen, Hao, Shulin Chen, Jie Lu, et al.. (2017). Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China. Cancer Prevention Research. 10(9). 542–550. 8 indexed citations
18.
Xu, Yi‐Wei, Xinyi Huang, Chao‐Qun Hong, et al.. (2017). Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma. Disease Markers. 2017. 1–9. 17 indexed citations
19.
Li, Lan, Ming Liu, Wenxia Chen, et al.. (2017). Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma. Disease Markers. 2017. 1–6. 11 indexed citations
20.
Peng, Yu‐Hui, Yi‐Wei Xu, Tian‐Tian Zhai, et al.. (2015). Autoantibody Signatures Combined with Epstein–Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma. Cancer Prevention Research. 8(8). 729–736. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Wei Xu Breakdown of academic impact, for papers by Yu Jiang Breakdown of academic impact, for papers by Yoshiyuki Yamamoto Breakdown of academic impact, for papers by Yin Liu Breakdown of academic impact, for papers by Carly C. Barron Breakdown of academic impact, for papers by Mengmeng Wang Breakdown of academic impact, for papers by Hengyuan Li Breakdown of academic impact, for papers by Nilgün Kapucuoğlu Breakdown of academic impact, for papers by Yunshan Wang
Rankless by CCL
2026